Myeloid Malignancies

specific

A malignant neoplasm composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone.

36

Centers

1

Active Trials

$70M

Cancer Funding

Top Centers for Myeloid Malignancies(36)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
90.3
2
NCI Comprehensive
Active Research Program
66.8
3
NCI Comprehensive
Active Research Program
65.8
4
NCI Comprehensive
Active Research Program
64.9
5
NCI Comprehensive
Active Research Program
63.9
6
NCI Comprehensive
Active Research Program
62.9
7
NCI Comprehensive
Active Research Program
61.9
8
NCI Comprehensive
Active Research Program
61.0
9
NCI Comprehensive
Active Research Program
60.0
10
NCI Comprehensive
Active Research Program
59.0
11
NCI Comprehensive
Active Research Program
58.1
12
NCI Comprehensive
Active Research Program
57.1
13
NCI Clinical
Active Research Program
56.1
14
NCI Comprehensive
Active Research Program
55.1
15
NCI Comprehensive
Active Research Program
54.2
16
NCI Basic_laboratory
Active Research Program
53.2
17
NCI Comprehensive
Active Research Program
52.2
18
NCI Comprehensive
Active Research Program
51.2
19
NCI Clinical
Active Research Program
50.3
20
NCI Comprehensive
Active Research Program
49.3
2148.3
22
NCI Comprehensive
Active Research Program
47.4
23
NCI Comprehensive
Active Research Program
46.4
24
Active Research Program
45.4
25
NCI Comprehensive
Active Research Program
44.4
26
NCI Comprehensive
Active Research Program
43.5
27
NCI Comprehensive
38.1
28
NCI Comprehensive
38.1
29
NCI Comprehensive
38.1
3038.1
31
Cedars-Sinai CancerLos Angeles, CA
38.1
32
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
38.1
3338.1
3438.1
35
NCI Comprehensive
38.1
3638.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →